Mar 22 | Sep 21 | Mar 21 | Sep 20 | Mar 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 19.57M | $ 16.43M | $ 32.82M | $ 19.28M | $ 11.69M |
Total Assets | $ 81.23M | $ 79.99M | $ 79.27M | $ 72.52M | $ 50.65M |
Total Debt | $ 29.29M | $ ― | $ 28.51M | $ 25.07M | $ 14.82M |
Net Debt | $ 9.72M | $ ― | $ -4.31M | $ 5.79M | $ 3.14M |
Total Liabilities | $ 58.02M | $ 59.31M | $ 55.66M | $ 50.43M | $ 32.83M |
Stockholders Equity | $ 23.20M | $ 20.68M | $ 23.61M | $ 22.09M | $ 17.82M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |